BRIEF-EMA Recommends Cutaneous Small Vessel Vasculitis To Be Added As Side Effect To Product Information Of Janssen Vaccine

European Medicines Agency:

* EMA: CUTANEOUS SMALL VESSEL VASCULITIS WAS RECOMMENDED BY PRAC TO BE ADDED AS SIDE EFFECT TO PRODUCT INFORMATION OF COVID-19 VACCINE JANSSEN Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)